Kolexia
Chastagner Pascal
Pédiatrie
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
197 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Gliome Leucémie-lymphome lymphoblastique à précurseurs B et T Neuroblastome Médulloblastome Tumeurs du cerveau Récidive tumorale locale Leucémie aigüe myéloïde Sarcomes

Industries

B3TSI
8 collaboration(s)
Dernière en 2022
Ethypharm
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

BIOMEDE 2: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Essai Clinique (Chimerix)   29 février 2024
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
European journal of cancer (Oxford, England : 1990)   15 février 2024
PLGG - MEKTRIC: A Randomized and Controlled Phase II Protocol in Non NF1 Pediatric and AYA (Adolescent and Young Adults) Patients Bearing a Newly Diagnosed Low Grade Glioma With Wild Type BRAF Gene Comparing a Daily Oral MEK Inhibitor (Trametinib) Versus Weekly Vinblastine for 18 Months
Essai Clinique (CHU Strasbourg)   15 février 2024
MICCHADO: Molecular and Immunological Characterisation of High Risk CHildhood Cancer At DiagnOsis, Treatment and Follow-up - Biological Evaluation in Children, Adolescents and Young Adults -
Essai Clinique (Institut Curie)   02 février 2024
Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus.
Blood   16 janvier 2024
Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population.
Cancer medicine   10 janvier 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   08 janvier 2024
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors.
European journal of cancer (Oxford, England : 1990)   06 janvier 2024
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.
Communications biology   18 septembre 2023
SIOP-EP-II: An International Clinical Program for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Ependymoma
Essai Clinique (Centre Léon-Bérard)   13 septembre 2023